Skip to main navigation Molecular Partners About Us DARPin Biology The DARPin Platform Pipeline Investors NEWS RELEASE DETAILS MOLECULAR PARTNERS ANNOUNCES PRESENTATION AT THE EVERCORE ISI 4TH ANNUAL HEALTHCONX CONFERENCE November 24, 2021 Download PDF ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Nov 30, 2021, at 8:00 AM EST. The webcasted presentation will be made available on the Molecular Partners website. About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com; Find us on Twitter - @MolecularPrtnrs For further details, please contact: Seth Lewis seth.lewis@molecularpartners.com Tel: +1 781 420 2361 Shai Biran, Ph.D. shai.biran@molecularpartners.com Tel: +1 978 254 6286 Thomas Schneckenburger, European IR & Media thomas.schneckenburger@molecularpartners.com Tel: +41 79 407 9952 INVESTORS > SIDEBAR MENU Overview News & Events News Releases Events Presentations Scientific Documents Stock Information Corporate Governance Financials & Filings General Meeting IR Resources > Footer Menu COOKIE NOTICE PRIVACY & DISCLAIMER CONTACT US > Footer Social © 2021 Molecular Partners.

Skip to main navigation Molecular Partners About Us DARPin Biology The DARPin Platform Pipeline Investors FINANCIAL REPORTS October 28, 2021 Q3 2021 Financial Statement Q3 2021 Financial Statement August 26, 2021 Half Year Report 2021 Half Year Report 2021 February 26, 2021 Annual Report FY2020 Annual Report FY2020 August 26, 2020 Half Year Report 2020 Half Year Report 2020 March 20, 2020 Annual Report FY2019 Annual Report FY2019 August 27, 2019 Half Year Report 2019 Half Year Report 2019 March 15, 2019 Annual Report FY2018 Annual Report FY2018 August 30, 2018 Half Year Report 2018 Half Year Report 2018 March 16, 2018 Annual Report FY2017 Annual Report FY2017 August 30, 2017 Half Year Report 2017 Half Year Report 2017 Pagination Current page 1 Page 2 Next page next › Last page last » INVESTORS > SIDEBAR MENU Overview News & Events Scientific Documents Stock Information Corporate Governance Financials & Filings SEC Filings Financial Reports General Meeting IR Resources > Footer Menu COOKIE NOTICE PRIVACY & DISCLAIMER CONTACT US > Footer Social © 2021 Molecular Partners.